Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of selective alpha 1A receptor antagonists on the iris dilator muscle
2015-003061-28Phase 4Terminated
- Sponsor
- Vienna Institute for Research in Ocular Surgery
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tamsulosin in Iris dilator muscle disorder (2 arms), sponsored by Vienna Institute for Research in Ocular Surgery. Started Jul 2015; status: terminated.
02
Drugs
tamsulosin
03
Conditions
Iris dilator muscle disorder
Beyond the preview
Go deeper on 2015-003061-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003061-28.